Study of Bitopertin to Evaluate the Safety, Tolerability, Efficacy, and PPIX Concentrations in Participants With EPP

NCT05308472 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

75

Enrollment

INDUSTRY

Sponsor class

Conditions

Erythropoietic Protoporphyria

Interventions

DRUG: DISC-1459
DRUG: DISC-1459
DRUG: Placebo

Sponsor

Disc Medicine, Inc